Broijl, A., Kersten, M.-J., Alemayehu, W. G., Levin, M.-D., de Weerdt, O., Vellenga, E., Meijer, E., Wittebol, S., Tanis, B. C., Cornelisse, P. B., Stevens-Kroef, M., Bos, G. M., Wijermans, P. W., Lokhorst, H. and Sonneveld, P. (2016) “Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma”, Haematologica. Pavia, Italy, 101(4), pp. e149-e152. doi: 10.3324/haematol.2015.132431.